Coiled-coil domain containing 6 (CCDC6) is frequently rearranged in papillary thyroid carcinomas participating in the formation of RET/PTC1 oncogene. Other rearrangements involving CCDC6 have also been identified demonstrating its high susceptibility to chromosomal recombination. Malignancies bearing CCDC6 fusion genes are developed in a background where CCDC6 is either lost or deregulated. Our aim was to identify interacting proteins which are affected by the silencing of CCDC6 expression and could possibly link CCDC6 deregulation to cancer causality. Therefore, a proteomic approach was adopted using a human cancer cell-line (HCT116) where CCDC6 expression was silenced by lentiviral shRNA constructs. 14-3-3σ down-regulation in the absence of CCDC6 was revealed and verified by western blot analysis and confocal microscopy. Only the levels and not the topology of CCDC6 were altered. The down-regulation of 14-3-3σ in the absence of CCDC6 demonstrated their direct association and supports the notion that CCDC6 contributes to cancer development, possibly through malignant pathways involving 14-3-3σ.
Download full-text PDF |
Source |
---|
Int J Mol Sci
November 2024
Department of Pathology, Institute for Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
Despite the existence of effective therapy options for patients with localized colorectal cancer, advanced-stage patients have limited therapies. Genomic profiling is a promising tool for guiding treatment selection as well as patient monitoring. Here, we describe a novel gene rearrangement () detected in a patient with advanced colorectal cancer that could be a therapeutic target.
View Article and Find Full Text PDFCancers (Basel)
October 2024
Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.
Int J Mol Sci
October 2024
Department of Medicine and Oncology, Faculty of Medicine, Semmelweis University, 1083 Budapest, Hungary.
Thyroid cancer is the most common type of endocrine malignancy. Papillary thyroid carcinoma (PTC) is its predominant subtype, which is responsible for the vast majority of cases. It is true that PTC is a malignant tumor with a very good prognosis due to effective primary therapeutic approaches such as thyroidectomy and radioiodine (RAI) therapy.
View Article and Find Full Text PDFAdv Ther
November 2024
Real-World Solutions, IQVIA, Shanghai, China.
Thyroid
October 2024
Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
The rearranged during transfection () proto-oncogene fusion is common in papillary thyroid cancer (PTC), varying across ethnic groups. However, comprehensive comparisons of fusion types are limited. This study aims to identify predominant fusions and analyze their clinicopathological characteristics in a cohort of Chinese thyroid cancer cases.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!